Enhancing Asthma Pharmacogenetics Through Subtype-Specific Associations.
作者信息
Piparia Shraddha, Hecker Julian, Srivastava Upasna, Sharma Rinku, Khare Manaswitha, Kho Alvin, Weiss Scott T, McGeachie Michael, Tantisira Kelan
机构信息
Division of Pediatric Respiratory Medicine, University of California at San Diego, San Diego, California, USA.
Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Clin Exp Allergy. 2025 Feb;55(2):193-195. doi: 10.1111/cea.14573. Epub 2024 Oct 2.
Abstract
摘要
相似文献
1
Enhancing Asthma Pharmacogenetics Through Subtype-Specific Associations.通过亚型特异性关联增强哮喘药物遗传学
Clin Exp Allergy. 2025 Feb;55(2):193-195. doi: 10.1111/cea.14573. Epub 2024 Oct 2.
2
Pharmacogenomics of inhaled corticosteroids and leukotriene modifiers: a systematic review.吸入性糖皮质激素和白三烯调节剂的药物基因组学：一项系统评价
Clin Exp Allergy. 2017 Feb;47(2):271-293. doi: 10.1111/cea.12844. Epub 2016 Dec 9.
3
Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium.儿童哮喘多民族药物基因组学联盟的基本原理与设计
Pharmacogenomics. 2017 Jul;18(10):931-943. doi: 10.2217/pgs-2017-0035. Epub 2017 Jun 22.
4
Pharmacogenetic and pharmacogenomic considerations of asthma treatment.哮喘治疗的药物遗传学和药物基因组学考量
Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1159-1167. doi: 10.1080/17425255.2017.1391215. Epub 2017 Oct 23.
5
Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.吸入性糖皮质激素与长效β受体激动剂联合作为持续性哮喘控制和快速缓解治疗与病情加重及症状控制的关联：一项系统评价和荟萃分析
JAMA. 2018 Apr 10;319(14):1485-1496. doi: 10.1001/jama.2018.2769.
6
Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.基于痰液嗜酸性粒细胞与临床症状的针对儿童和成人哮喘的个性化干预措施。
Cochrane Database Syst Rev. 2017 Aug 24;8(8):CD005603. doi: 10.1002/14651858.CD005603.pub3.
7
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.吸入长效β2受体激动剂与吸入性糖皮质激素联合使用与高剂量吸入性糖皮质激素治疗儿童和成人持续性哮喘的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005533. doi: 10.1002/14651858.CD005533.
8
Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.长效β2受体激动剂与安慰剂用于慢性哮喘儿童和成人并联合吸入性糖皮质激素的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005535. doi: 10.1002/14651858.CD005535.
9
Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.应用于哮喘研究的药物遗传学与药物基因组学综述
Methods Mol Biol. 2016;1434:255-72. doi: 10.1007/978-1-4939-3652-6_18.
10
Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma.药物基因组学：迈向儿童哮喘精准医学的一步。
Genes (Basel). 2022 Mar 28;13(4):599. doi: 10.3390/genes13040599.
本文引用的文献
1
Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?我们是否满足了哮喘的表型和精准医学的承诺？
Physiol Rev. 2020 Jul 1;100(3):983-1017. doi: 10.1152/physrev.00023.2019. Epub 2020 Jan 9.
2
Predicting inhaled corticosteroid response in asthma with two associated SNPs.用两个相关的 SNP 预测哮喘患者吸入皮质激素的反应。
Pharmacogenomics J. 2013 Aug;13(4):306-11. doi: 10.1038/tpj.2012.15. Epub 2012 May 29.
3
Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus.全基因组关联分析鉴定 T 基因是一个新的哮喘药物遗传学位点。
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1286-91. doi: 10.1164/rccm.201111-2061OC. Epub 2012 Apr 26.
4
Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma.GLCCI1 基因与哮喘患者糖皮质激素治疗反应的全基因组关联研究。
N Engl J Med. 2011 Sep 29;365(13):1173-83. doi: 10.1056/NEJMoa0911353. Epub 2011 Sep 26.
5
PLINK: a tool set for whole-genome association and population-based linkage analyses.PLINK：一个用于全基因组关联分析和基于群体的连锁分析的工具集。
Am J Hum Genet. 2007 Sep;81(3):559-75. doi: 10.1086/519795. Epub 2007 Jul 25.
6
Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.皮质类固醇药物遗传学：CRHR1基因序列变异与吸入皮质类固醇治疗的哮喘患者肺功能改善的关联
Hum Mol Genet. 2004 Jul 1;13(13):1353-9. doi: 10.1093/hmg/ddh149. Epub 2004 May 5.
7
Long-term effects of budesonide or nedocromil in children with asthma.布地奈德或奈多罗米对哮喘儿童的长期影响。
N Engl J Med. 2000 Oct 12;343(15):1054-63. doi: 10.1056/NEJM200010123431501.
8
The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group.儿童哮喘管理项目（CAMP）：设计、基本原理及方法。儿童哮喘管理项目研究组
Control Clin Trials. 1999 Feb;20(1):91-120.
Zotero 插件